Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quintuple Method for Refractory Colorectal Liver Metastases
NCT05774964Phase 2Unknown
- Sponsor
- Liaoning Medical Center
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole, vitamin a, folic acid in Colorectal cancer with liver metastases (CRLM), sponsored by Liaoning Medical Center. Status: unknown.
02
Drugs
metronidazolevitamin afolic acid
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT05774964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774964.